US Broker Ratings

Privia Health Group, Inc. (PRVA): Analyst Consensus Suggests a 47.71% Upside Potential

Investors looking into the healthcare sector might want to pay close attention to Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the health information services industry. With a..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 29% Upside Potential with Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC) is capturing investor attention with its robust growth in revenue and a potential upside of nearly 30%, according to analyst estimates. The company, based in..

Concentra Group Holdings (CON) Stock Analysis: Potential for 30% Upside in Healthcare Sector

Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is catching the attention of investors with a compelling potential..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Biotechnology Innovator with a 45% Upside Potential

For investors seeking exposure in the biotechnology sector, MoonLake Immunotherapeutics (NASDAQ: MLTX) offers a compelling opportunity. With a focus on innovative treatments for inflammatory skin and joint diseases, this Swiss-based..

Warby Parker Inc. (WRBY) Stock Analysis: Exploring a 12.97% Upside Potential

Warby Parker Inc. (NYSE: WRBY), a prominent player in the eyewear industry, is drawing attention from investors with its potential upside of 12.97%. Renowned for transforming the optical market with..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 214% Potential Upside

In the dynamic world of biotechnology, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling case for investors with a significant upside potential. Known for its innovative approach to treating rare..

Amedisys Inc (AMED): Analyst Consensus and Growth Potential in the Healthcare Sector

Amedisys Inc. (NASDAQ: AMED) stands as a notable player in the healthcare industry, particularly within the medical care facilities segment. With a market capitalization of $3.32 billion, Amedisys is well-positioned..

DENTSPLY SIRONA Inc. (XRAY): Investor Outlook with a 35% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $2.5 billion, DENTSPLY SIRONA..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: High Revenue Growth Amidst Strategic Biotech Innovations

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands as a promising figure in the biotechnology sector, driven by its focus on developing therapies for rare diseases and cancers. With a market capitalization..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Growth Potential and Analyst Consensus Signal a Promising Future

iRhythm Technologies, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector, specifically within the medical devices industry, is attracting attention from investors for its innovative approach to cardiac monitoring...

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unlocking a 23.58% Upside Potential with Solid Analyst Confidence

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, is renowned for its advanced medical devices and diagnostics. With a market capitalization of $7.12 billion, the company..

Vaxcyte, Inc. (PCVX) Stock Analysis: A 284% Potential Upside Awaits Investors

Vaxcyte, Inc. (NASDAQ: PCVX), a biotechnology company dedicated to revolutionizing vaccine development, is capturing investor attention with its impressive potential upside of 284.20%. As the company advances its innovative pipeline,..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook Reveals 26.81% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing attention in the biotechnology sector with its promising focus on developing treatments for metabolic dysfunction-associated steatohepatitis (MASH). Headquartered in West Conshohocken, Pennsylvania, Madrigal..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unpacking the 48.20% Potential Upside in Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, standing out for its innovative approach to genetic medicines. With a market cap of $4.01 billion, this Pittsburgh-based..

TransMedics Group, Inc. (TMDX) Stock Analysis: Potential 24% Upside Amid Strong Revenue Growth

TransMedics Group, Inc. (NASDAQ: TMDX) is a pioneering force in the healthcare sector, specifically within the medical devices industry, with a focus on revolutionizing organ transplant therapy. Headquartered in Andover,..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating Growth in the Biotech Sector

Blueprint Medicines Corporation (NASDAQ: BPMC), a leading player in the biotechnology sector, continues to capture investor attention with its innovative approaches to treating genomically defined cancers and blood disorders. Headquartered..

Legend Biotech Corporation (LEGN) Stock Analysis: A Promising Biotech with a Potential Upside of 106%

Legend Biotech Corporation (NASDAQ: LEGN), a burgeoning force in the biotech sector, is catching the eye of investors with its robust growth potential and strategic focus on cutting-edge cell therapies...

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Evaluating a 24.85% Potential Upside Amidst Biotech Volatility

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, is at a pivotal point that presents a unique opportunity for investors. With its current market cap at..

BrightSpring Health Services (BTSG) Stock Analysis: Healthcare Innovator with 38% Upside Potential

BrightSpring Health Services, Inc. (BTSG) has captured the attention of investors with its robust growth prospects and a compelling potential upside of 38.15%. As a key player in the Healthcare..

Exact Sciences Corporation (EXAS) Stock Analysis: A 56% Potential Upside in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) stands as a prominent player in the healthcare sector, specifically in diagnostics and research. With a market capitalization of $7.76 billion, the company has carved..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds